← Contracts
PT
Aquisição de Ocrelizumab 300 mg/10 ml Sol inj Fr 10 ml IV à Roche Farmacêutica Química, Lda.
ID 10991441
· Portal BASE
Price
Base Price
€19,999
.00
Effective Price
€19,999
.00
0.0%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ajuste Direto Regime Geral
- CPV Code
- 33600000
- Location
- Portugal, Portalegre, Elvas Portugal, Portalegre, Portalegre
- Bidder Count
- —
Winner
ROCHE FARMACEUTICA QUIMICA LDA
NIF 500233810
Dates
- Publication
- 25 Oct 2024
- Celebration
- 04 Sep 2024
Contracting Entity
Unidade Local de Saúde do Norte Alentejano, EPE
NIF 508094461
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 75 · HIGH RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
- Publication Date
- 25 Oct 2024
- Signing Date
- 04 Sep 2024
- Days Late
- 51
- Rule
- A2/A3 late publication: 51 days after signing (threshold: 10)
Detected 2026-03-06
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
- Base price
- 19999.0
- Threshold
- 20000.0
- Rule
- A5 threshold splitting: price within 5% below 20000.0
Detected 2026-03-06